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We are in the midst of a well-publicized, worldwide obesity
epidemic (1). Yet, despite its known deleterious multiorgan
effects at an individual level and the economic constraints
of obesity-related illnesses on global health systems, there
remains an ongoing debate regarding the impact of obesity
on mortality rates. Fueling this debate has been the recent
publication of 2 large-scale but somewhat conﬂicting meta-
analyses. Although 1 analysis concluded that nearly one-ﬁfth
of total mortality within the United States is attributable to
obesity (2), by contrast, the other uncovered possible pro-
tective effects of being overweight, with greater survival
observed among people with body mass indexes (BMIs)
between 25 and 30 kg/m2 than among a normal-weight
cohort (BMIs between 18.5 and 25 kg/m2) (3). Even
more controversial has been the concept of “metabolically-
healthy obesity,” deﬁned as an obese (BMI >25 kg/m2)
state without demonstrable obesity-related metabolic abnor-
malities such as dyslipidemia or impaired glucose tolerance.See page 2679Consequently, some have postulated that metabolically-
healthy obese people need not receive preventative therapies,
because they would appear unlikely to experience long-term
morbidity on the basis of their seemingly normal metabolic
status (4). However, the incidence of obesity-related meta-
bolic abnormalities varies considerably among overweight
and obese people. Prior analyses that evaluated the prognosis
of metabolically-healthy obese people have been ﬂawed by
their inability to quantify changes in metabolic parameters
over time. Additionally, the inclusion of patients with known
cardiovascular risk factors in the metabolically-healthy
obese group and overweight people in the normal comparator
group confounded some of these prior comparisons (5).*Editorials published in the Journal of the American College of Cardiology reﬂect the
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to disclose.Nevertheless, this has left many to ponder whether obesity
per se or component metabolic abnormalities mediate car-
diovascular risk.
With this in mind, in this issue of the Journal, Chang
et al. (6) report a comparison of coronary artery calcium
(CAC) scores between metabolically-healthy obese versus
metabolically-healthy normal-weight Koreans (6). Their
rationale was based on the notion that CAC scoring is a
surrogate means of assessing subclinical coronary athero-
sclerosis, with known signiﬁcant associations with incident
major adverse cardiovascular events, and that this imaging
method might illuminate the true relationship between
obesity, metabolic health, and subclinical atherosclerotic
cardiovascular disease. The overall population sample con-
sisted of 14,828 metabolically-healthy people (mean age of
39 years, >74% male) who took part in a comprehensive
regional health screening program. Metabolic health was
deﬁned as the absence of all of the following: fasting blood
glucose 100 mg/dl (or use of glucose-lowering agents),
blood pressure 130/85 mm Hg (or use of blood pressure–
lowering agents), triglycerides 150 mg/dl (or use of lipid-
lowering therapies), high-density lipoprotein cholesterol
<40 mg/dl in men (or <50 mg/dl in women), and a ho-
meostasis model of insulin resistance 2.5. A comprehen-
sive questionnaire pertaining to past medical history and
measures of physical activity, alcohol consumption, and
smoking habits was also collected. All patients had BMI
measured; however, less than one-third of the population
had waist circumference measured. This metabolically-
healthy population was then stratiﬁed according to BMI into
1 of 4 categories: underweight (BMI <18.5 kg/m2), normal
weight (BMI 18.5 to 22.9 kg/m2), overweight (BMI 23.0 to
24.9 kg/m2), and obese (BMI 25 kg/m2). CAC scores
were analyzed across these BMI strata.
Across a series of analyses that adjusted for potential con-
founding variables, and across a range of CAC score categories
(Agatston scores 1 to 80 and >80), the metabolically-healthy
obese group had a signiﬁcantly greater prevalence of coronary
atherosclerosis than their metabolically-healthy but normal-
weight counterparts. However, after additional adjustment
for metabolic risk factors and low-density lipoprotein choles-
terol levels, the greater prevalence of subclinical coronary
atherosclerosis in the metabolically-healthy obese group no
longer remained statistically signiﬁcant. The authors drew 2
major conclusions from their analyses: 1) an obese yet meta-
bolically healthy state was associated with a greater prevalence
of subclinical coronary atherosclerosis, and therefore, obesity
cannot be considered a benign condition; and 2) despite the
fact that the metabolic risk parameters of the participants fell
well within the normally accepted range, it appeared that the
association between a metabolically-healthy obese state and
subclinical coronary artery disease was still ultimately deter-
mined by component metabolic parameters that fell below
speciﬁc laboratory/clinical threshold levels.
The analysis by Chang et al. (6) was limited by its cross-
sectional design, the lack of anthropometric tools used to
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2688better assess levels of visceral fat, and its conﬁnement to a
young Korean population. Furthermore, the use of CAC
scoring in such a young, low-risk population for population
health screening is currently controversial and must be
highlighted. That being said, the results are concordant with
the ﬁndings of a recent large-scale meta-analysis by Kramer
et al. (7), who analyzed all-cause and cardiovascular mor-
tality across 8 studies comprising >60,000 people followed
up for at least 10 years. Compared with metabolically-
healthy normal-weight people, metabolically-healthy obese
people were at signiﬁcantly greater risk for death and car-
diovascular events, which afﬁrms the notion that obesity
portends an adverse long-term prognosis irrespective of the
presence or absence of concomitant metabolic abnormalities.
The studies by Chang et al. (6) and Kramer et al. (7) cast
serious doubt on the concept of obese people maintaining a
benign prognosis and highlight the fact that obesity per se
is a genuine disease. They also seriously call into question
the fundamental concept of the quest to deﬁne a subset of
obese people as metabolically healthy. Is it simply to stim-
ulate academic debate, or is there a compelling clinical and
practical reason for doing so? If we were to ﬁnd a means of
labeling a subset of obese people as metabolically healthy, of
what beneﬁt would this be to society? Given our current lack
of a “cure” or efﬁcient means of successfully treating obesity
over the longer term, might the resources spent on trying to
deﬁne and justify the existence of a metabolically-healthy
obese population be more wisely allocated to elucidating
ways to prevent or treat obesity? Obesity adversely affects
almost all physiological homeostatic mechanisms, and its
presence is associated with both cardiac and many non-
cardiometabolic disorders, including malignancy, infection,
infertility, joint disease, depression, and cognitive decline.
Our society faces a monumental challenge to successfully
tackle obesity and its complications. By labeling a subset of
obese people as metabolically healthy, would we not un-
dermine the ultimate task that physicians and health orga-
nizations face to curb the current obesity epidemic and
prevent the next generation of people from becoming
obese? Failure to promote weight loss strategies to all obese
people and a strategy of only offering treatment to obese
patients with overt metabolic derangements would appear
futile and short-sighted. Any perceived short- to medium-
term cost savings would be quashed by the inevitable
longer-term socioeconomic burden of treating numerous
noncardiometabolic ailments faced by obese people. It is also
prudent to note that obesity is not a disease acquired over-
night. People evolve from normal weight to being over-
weight before further evolution to an obese state. Although
the analysis by Chang et al. (6) failed to uncover a signiﬁ-
cantly greater burden of subclinical atherosclerotic disease in
the overweight compared with normal-weight people, the
meta-analysis by Kramer et al. (7) clearly demonstrated asigniﬁcant association between being overweight and car-
diovascular events. Given that overweight people are at
heightened risk for evolving into an obese state, in-
terventions that target the overweight population are equally
critical.
There is still much for us to learn about obesity and the
underlying molecular mechanisms of obesity-related organ
disease. A recent elegantly designed genome-wide analysis
uncovered the association between an obese phenotype and
deoxyribonucleic acid methylation, with subsequent alter-
ation of the functional status of HIF3A, a gene involved in
the regulation of physiological responses to hypoxia (8). This
epigenetic phenomenon is just 1 example of the deleterious
effects of obesity. The “omics” revolution, coupled with
vascular imaging, is likely to yield tremendous insight into
factors that promote cardiovascular disease across a variety of
population subsets, with the obese population being a pri-
mary target for such investigations. This will foster the
development of more speciﬁc and targeted therapies for
tackling obesity. But ﬁrst, we must simply accept obesity as a
disease and consider no level of obesity to be healthy. The
analysis by Chang et al. (6) strengthens the argument that
“healthy obesity” is simply a myth.
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